Eloisa sells SGEN 40.9: 'Axl' rose blooms again: Seattle Genetics' Genmab hookup worth more than $200
So it's hard to say what the benchmarks are in a phase I population. I think you'll have to judge from the data when you see [them]." The company's stock (NASDAQ:SGEN) closed Wednesday at $41.98, up $1.86. ...
40 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home